Pharmaceutisch Weekblad

, Volume 10, Issue 6, pp 246–253 | Cite as

Sublingual nitroglycerin

I. Comparative evaluation of the physical stability of commercially available tablets
  • M. Lagas
  • A. M. J. A. Duchateau
Original Articles


The physical stability of one type of stabilized molded and three types of compressed nitroglycerin tablets was studied. The evaporation rate of nitroglycerin was controlled by its vapour pressure and by the matrix effect of the dosage forms. The four products showed different vapour pressures and matrix effects. In time nitroglycerin escapes from the outmost layers of the tablets; the dosage form in which the drug showed the lowest vapour pressure (the stabilized molded tablet) was found to be the most stable one. However, from the time when the drug had escaped from the outmost layers of the dosage form, the matrix effect became dominant. When nitroglycerin tablets were stored in tightly closed containers at room temperature potency loss was minimal. Even when the bottles were opened regularly this did not result in a significant loss of the drug. Measures are suggested to minimize drug evaporation.


Content uniformity Drug compounding Drug packaging Drug stability Drug storage Glyceryl-trinitrate Tablets 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Banes D. Deterioration of nitroglycerin tablets. J Pharm Sci 1968;57:893–4.PubMedGoogle Scholar
  2. 2.
    Edelman BA, Contractor AM, Shangraw RF. The stability of hypodermic tablets of nitroglycerin packaged in dispensing containers. J Am Pharm Assoc 1971;NS11:30–5.Google Scholar
  3. 3.
    Fusari SA. Nitroglycerin sublingual tablets, I: stability of conventional tablets. J Pharm Sci 1973;62:122–9.PubMedGoogle Scholar
  4. 4.
    Page DP, Carson NA, Buhr CA, Flinn PE, Wells CE, Randall MT. Stability study of nitroglycerin sublingual tablets. J Pharm Sci 1975;64:140–7.PubMedGoogle Scholar
  5. 5.
    Shangraw RF, Dorsch B. Stability of nitroglycerin tablets in a unit of use pendant-type container. Cont Pharm Pract 1981;4:132–6.Google Scholar
  6. 6.
    Crabbs WC, Dow ML, Juhi YM, Page DP. Stability of nitroglycerin tablets submitted by U.S. hospitals. Am J Hosp Pharm 1983;40:2170–5.PubMedGoogle Scholar
  7. 7.
    Fusari SA. Nitroglycerin sublingual tablets. II: preparation and stability of a new stabilized, sublingual, molded nitroglycerin tablet. J Pharm Sci 1973;62:2012–21.PubMedGoogle Scholar
  8. 8.
    Pikal MJ, Lukes AL, Ellis LF. Vapor pressure of nitroglycerin in sublingual molded tablets: implications for stability. J Pharm Sci 1976;65:1278–84.PubMedGoogle Scholar
  9. 9.
    Goodharts FW, Gucluyildiz H, Daly RE, Chafetz L, Ninger FC. Stabilized compressed nitroglycerin tablets. J Pharm Sci 1976;65:1466–71.PubMedGoogle Scholar
  10. 10.
    Crouthamel WG, Dorsch B. Specific high-performance liquid Chromatographic assay for nitroglycerin in dosage forms. J Pharm Sci 1979;68:237–8.PubMedGoogle Scholar

Copyright information

© Bohn, Scheltema & Holkema 1988

Authors and Affiliations

  • M. Lagas
    • 1
  • A. M. J. A. Duchateau
    • 2
  1. 1.Laboratory for Pharmaceutical ResearchSH Rodenthe Netherlands
  2. 2.Central Hospital Pharmacy 's-HertogenboschJL 's-Hertogenboschthe Netherlands

Personalised recommendations